Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
Go back to Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026| Dominion Resources (NYSE: D) | Delayed: 71.09 +1.24 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.85 | 52 Week High | $78.97 | |||
| Open | $70.39 | 52 Week Low | $64.54 | |||
| Day High | $71.23 | P/E | 59.24 | |||
| Day Low | $70.15 | EPS | $1.20 | |||
| Volume | 3,273,079 | |||||
| Ryder System (NYSE: R) | Delayed: 276.37 +1.80 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $274.57 | 52 Week High | $80.15 | |||
| Open | $274.04 | 52 Week Low | $45.12 | |||
| Day High | $278.07 | P/E | 59.69 | |||
| Day Low | $274.04 | EPS | $4.63 | |||
| Volume | 400,363 | |||||
